Frequently asked questions References STEP 1 Trial: Semaglutide 2.4 mg for Weight Management (NEJM, 2021) GLP-1 Receptor Agonists: Mechanism and Clinical Use (PubMed) Semaglutide Prescribing Trends (JAMA Network Open, 2023) FDA Drug Shortage Database: Semaglutide Wegovy Prescribing Information (FDA) Endocrine Society Guidelines: Pharmacological Management of Obesity CDC: Healthy Weight Loss Safety Profile of GLP-1 RAs (PubMed, 2022) Glycogen and Water Weight (PubMed) Lean Mass Preservation During Weight Loss (PubMed) Medullary Thyroid Carcinoma Risk and GLP-1 RAs (PubMed)
Amylin, a company initially developing exenatide, focused on the design of a PLGA polymer extended release formulation of exenatide in partnership with Alkermes
Other studies have noted potential benefits for improving mobility, strength, and flexibility in joints and connective tissue
IGF-1 Blood Test Why Do I Need to Have My HGH Level Tested First
Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation
Zhou M, Mok MT, Sun H, Chan AW, Huang Y, Cheng AS, et al